FIELD: medicine.;SUBSTANCE: group of inventions relates to the field of medicine, namely, to a method for the prevention or treatment of fibromyalgia or associated functional symptoms of fibromyalgia in a subject, including the injection of therapeutically effective amount of (R)-1-(2-chlorophenyl)-2-tetrazole-2-yl)ethyl ether of carbamic acid, or its pharmaceutically acceptable salt to a subject, where the associated functional symptoms of fibromyalgia are selected from a group consisting of body temperature disorder, irritable bowel syndrome, symptoms of Sikka, hyperhidrosis (increased sweating), dizziness, tremor, dyspnea, arrhythmias, paresthesia and chronic fatigue, as well as to the use of(R)-1-(2-chlorophenyl)-2-tetrazole-2-yl)ethyl ether of carbamic acid, or its pharmaceutically acceptable salt for the prevention or treatment of fibromyalgia or associated functional symptoms of fibromyalgia. ;EFFECT: group of inventions provides for effective prevention and treatment of fibromyalgia and associated functional symptoms of fibromyalgia, where the associated functional symptoms of fibromyalgia are selected from a group consisting of body temperature disorder, irritable bowel syndrome, symptoms of Sikka, hyperhidrosis (increased sweating), dizziness, tremor, dyspnea, arrhythmias, paresthesia and chronic fatigue.;8 cl, 2 dwg, 1 tbl, 1 ex
展开▼